Sign in
ROIVW Stock Price, Chart, Stats & News
Roivant Sciences Ltd.
Save
Roivant Sciences Ltd. (ROIVW) does not currently pay a dividend.
1.97B
Market cap
–
Current P/E
–
Forward P/E
ROIVW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 91.21% |
Operating margin | -9130.53% |
Pretax margin | -6925.09% |
Net margin | -6079.94% |
Effective tax rate | -9.15% |
ROA | -15.49% |
ROE | -18.32% |
D/E | 0.05x |
Interest coverage ratio | – |
ROIVW valuation
P/E | – |
P/S | 1426.02x |
P/B | 4.33x |
P/CF | -24.35x |
P/FCF | -24.75x |
P/OCF | -24.35x |
PEG | 0.21x |
EV multiple | -19.95x |
About
Roivant Sciences Ltd. operates as a biopharmaceutical and healthcare technology enterprise, concentrating on the research and development of innovative pharmaceutical solutions. The firm's pipeline features investigational therapies aimed at a diverse range of diseases. These include various oncologic malignancies (such as solid tumors), blood conditions like sickle cell disease, rare genetic disorders such as hypophosphatasia, and a spectrum of dermatological ailments including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, and acne.
Similar securities
Based on sector and market capitalization
Report issue